The importance of heparan sulfate in herpesvirus infection

Virologica Sinica

Volumn 23, Issue 6, 2008, Pages 383-393

  O'Donnell, Christopher D ^a   Shukla, Deepak ^a  

^a UNIVERSITY OF ILLINOIS   (United States)

Author keywords

3 O sulfotransferases; Heparan sulfate (HS); Herpes simplex virus type 1 (HSV 1); Herpesviruses; Viral entry

Indexed keywords

3 O SULFATED OCTASACCHARIDE; 3 O SULFOTRANSFERASE; ANTIVIRUS AGENT; GLYCOPROTEIN B; GLYCOPROTEIN D; HEPARAN SULFATE; LACTOFERRICIN; LACTOFERRIN; LIGNIN; PROTEIN C; SULFOTRANSFERASE; UNCLASSIFIED DRUG;

ANTIVIRAL ACTIVITY; ARTICLE; BINDING SITE; CELL SURFACE; DRUG RECEPTOR BINDING; DRUG SULFATION; DRUG SYNTHESIS; EXTRACELLULAR MATRIX; HERPES SIMPLEX VIRUS 1; HUMAN; PHARMACOLOGICAL BLOCKING; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN MODIFICATION; PROTEIN TARGETING; VIRUS ATTACHMENT; VIRUS CELL INTERACTION; VIRUS ENTRY; VIRUS ENVELOPE; VIRUS INHIBITION;

HERPESVIRIDAE; HUMAN HERPESVIRUS 1; SIMPLEXVIRUS;

EID: 58049209246     PISSN: 16740769     EISSN: 1995820X     Source Type: Journal    
DOI: 10.1007/s12250-008-2992-1     Document Type: Article

References (92)

1. Akula S M, Wang F Z, Vierira J, et al. 2001. Human herpesvirus 8 (HHV8/ KSHV) infection of target cells involves interaction with heparan sulfate. Virology, 282(2): 245-255.
2. Andersen J H, Jenssen H, Gutteberg T J. 2003. Lactoferrin and lactoferricin inhibit herpes simplex 1 and 2 infection and exhibit synergy when combined with acyclovir. Antiviral Res, 58(3): 209-215.
3. Andersen, J H, Jenssen H, Sandvik K, et al. 2004. Anti-HSV activity of lactoferrin and lactoferricin is dependent on the presence of heparan sulphate at the cell surface. J Med Virol, 74(2): 262-271.
4. Bacon T H, Levin M J, Leary J L, et al. 2003. Herpes simplex virus resistance to acyclovir and penciclovir after two decades of antiviral therapy. Clin Microbiol Rev, 16(1): 114-128.
5. Barth H, Schafer C, Adah M I, et al. 2003. Cellular binding of hepatitis C virus envelope glycoprotein E2 requires cell surface heparan sulfate. J Biol Chem, 278(42): 41003-41012.
6. Brady R C, Bernstein D I. 2004. Treatment of herpes simplex virus infections. Antiviral Res, 61(2): 73-81.
7. Campadelli-Fiume G, Cocchi F, Menotti L, et al. 2000. The novel receptors that mediate the entry of herpes simplex viruses and animal alphaherpesviruses into cells. Rev Med Virol, 10(5): 305-319.
8. Carfi A, Willis S H, Whitbeck J C, et al. 2001. Herpes simplex virus glycoprotein D bound to the human receptor HveA. Mol Cell, 8(1): 169-179.
9. Chen J, Avci F Y, Munoz E M, et al. 2005. Enzymatically redesigning of biologically active heparan sulfate. J Biol Chem, 280(52): 42817-42825.
10. Chen Y, Maguire T, Hileman R E, et al. 1997. Dengue virus infectivity depends on envelope protein binding to target cell heparan sulfate. Nat Med 3(8): 866-871
11. Clement C, Tiwari V, Scanlan P M, et al. 2006. A novel role for phagocytosis-like uptake in herpes simplex virus entry. J Cell Biol, 174(7): 1009-1021.
12. Compton T, Nowlin D M, Cooper N R. 1993. Initiation of human cytomegalovirus infection requires initial interaction with cell surface heparan sulfate. Virology, 193(2): 834-841.
13. Copeland R, Balasubramaniam A, Tiwari V, et al. 2008. Using a 3-O-sulfated heparin octasaccharide to inhibit the entry of herpes simplex virus type 1. Biochemistry, 47(21): 5774-5783.
14. Corey L, Spear P G. 1986. Infections with herpes simplex viruses. N Engl J Med, 314(11): 686-691.
15. Dyer A P, Banfield B W, Martindale D, et al. 1997. Dextran sulfate can act as an artificial receptor to mediate a typespecific herpes simplex virus infection via glyco-protein B. J Virol, 71(1): 191-198.
16. Eizuru Y. 2003. Development of new antivirals for herpes-viruses. Antivir Chem Chemother, 14(6): 299-308.
17. Esko J D, Lindahl U. 2001. Molecular diversity of heparan sulfate. J Clin Invest, 108(2): 169-173.
18. Feyzi E, Trybala E, Bergstrom T, et al. 1997. Structural requirement of heparan sulphate for interaction with herpes simplex virus type 1 virions and isolated glycoprotein C. J Biol Chem, 272(40): 24850-24857.
19. Friedman H M, Cohen G H, Eisenberg R J, et al. 1984. Glycoprotein C of herpes simplex virus type 1 acts as a receptor for C3b component of complement on infected cells. Nature, 309(5969): 633-635.
20. Geraghty R J, Krummenacher C, Cohen G H, et al. 1998. Entry of alphaherpesviruses mediated by poliovirus receptor-related protein 1 and poliovirus receptor. Science, 280(5369): 1618-1620.
21. Hasegawa K, Motsuchi W, Tanaka S, et al. 1994. Inhibition with lactoferrin of in vitro infection with human herpes virus. Jpn J Med Sci Biol, 47(2): 73-85.
22. Hayashi T, Hayashi K, Maeda M, et al. 1996. Calcium spirulan, an inhibitor of enveloped virus replication, from a blue-green alga Spirulina platensis. J Nat Prod, 59(1): 83-87.
23. Herold B C, Gerber S I, Polonsky T, et al. 1995. Identification of structural features of heparin required for inhibition of herpes simplex virus type 1 binding. Virology, 206(2): 1108-1116.
24. Herold B C, Siston A, Bremer J, et al. 1997. Sulfated carbohydrate compounds prevent microbial adherence by sexually transmitted disease pathogens. Antimicrob. Agents Chemother, 41(12): 2776-2780.
25. Herold B C, Visalli R J, Susmarski N, et al. 1994. Glycoprotein C-independent binding of herpes simplex virus to cells requires cell surface heparan sulphate and glycoprotein B. J Gen Virol, 75(Pt 6): 1211-1222.
26. Herold B C, WuDunn D, Soltys N, et al. 1991. Glycoprotein C of herpes simplex virus type 1 plays a principal role in the adsorption of virus to cells and in infectivity. J Virol, 65(3): 1090-1098.
27. Hutton R D, Ewert D L, French G R. 1973. Differentiation of types 1 and 2 of herpes simplex virus by plaque inhibition with sulfated polyanions. Proc Soc Exp Biol Med, 142(1): 27-29.
28. Gerber S I, Belval B J, Herold B C. 1995. Differences in the role of glycoprotein C of HSV-1 and HSV-2 in viral binding may contribute to serotype differences in cell tropism. Virology, 214(1): 29-39.
29. Giroglou T, Florin L, Schafer F, et al. 2001. Human papillomavirus infection requires cell surface heparan sulfate. J Virol, 75(3): 1565-1570.
30. Gruenheid S, Gatzke L, Meadows H, et al. 1993. Herpes simplex virus infection and propagation in a mouse L cell mutant lacking heparan sulfate proteoglycans. J Virol, 67(1): 93-100.
31. Jacquet A, Haumont M, Chellun D, et al. 1998. The varicella zoster virus glycoprotein B (gB) plays a role in virus binding to cell surface heparan sulfate proteoglycans. Virus Res, 53(2): 197-207.
32. Jenssen H. 2005. Anti herpes simplex virus activity of lactoferrin/ lactoferricin-an example of antiviral activity of antimicrobial protein/ peptide. Cell Mol Life Sci, 62(24): 3002-3013.
33. Jenssen H, Andersen J H, Mantzilas D, et al. 2004. A wide range of medium-sized, highly cationic, alpha-helical peptides show antiviral activity against herpes simplex virus. Antiviral Res, 64(2): 119-126.
34. Jenssen H, Andersen J H, Uhlin-Hansen L, et al. 2004. Anti-HSV activity of lactoferricin analogues is only partly related to their affinity for heparan sulfate. Antiviral Res, 61(2): 101-109.
35. Jenssen H, Hamill P, Hancock R E. 2006. Peptide antimicrobial agents. Clin Microbiol Rev, 19(3): 491-511.
36. Jenssen H, Sandvik K, Andersen J H, et al. 2008. Inhibition of HSV cell-to-cell spread by lactoferrin and lactoferricin. Antiviral Res, 79(3): 192-198.
37. Inatani M, Irie F, Plump A S, et al. 2003. Mammalian brain morphogenesis and midline axon guidance require heparan sulfate. Science, 302(5647): 1044-1046.
38. Kwon H, Bai Q, Baek H J, et al. 2006. Soluble V domain of Nectin-1/HveC enables entry of herpes simplex virus type 1 (HSV-1) into HSV-resistant cells by binding to viral glycoprotein D. J Virol, 80(1): 138-148.
39. Langeland N, Holmsen H, Lillehaug J R, et al. 1987. Evidence that neomycin inhibits binding of herpes simplex virus type 1 to the cellular receptor. J Virol, 61(11): 3388-3393.
40. Langeland N, Moore L J, Holmsen H, et al. 1998. Interaction of polylysine with the cellular receptor for herpes simplex virus type 1. J Gen Virol, 69(Pt 6): 1137-1145.
41. Laquerre S, Argnani R, Anderson D B, et al. 1998. Heparan sulfate proteoglycan binding by herpes simplex virus type 1 glycoproteins B and C, which differ in their contributions to virus attachment, penetration, and cell-to-cell spread. J Virol, 72(7): 6119-6130.
42. Lee J B, Hayashi K, Hashimoto M, et al. 2004. Novel antiviral fucoidan from sporophyll of Undaria pinnatifida (Mekabu). Chem Pharm Bull (Tokyo), 52(9): 1091-1094.
43. Legrand D, Pierce A, Elass E, et al. 2008. Lactoferrin structure and functions. Adv Exp Med Biol, 606: 163-194.
44. Liang X, Babiuk L A, Zamb T J. 1993. Mapping of heparin-binding structures on bovine herpesvirus 1 and pseudorabies virus gIII glycoproteins. Virology, 194(1): 233-243.
45. Lindahl U, Kusche-Gullberg M, Kjellén L. 1998. Regulated diversity of heparan sulfate. J Biol Chem, 273(39): 24979-24982.
46. Liu J, Shriver Z, Pope R M, et al. 2002. Characterization of a heparan sulphate octasaccharide that binds to herpes simplex viral type 1 glycoprotein D. J Biol Chem, 277(36): 33456-33467.
47. Liu J, Shworak N W, Sinay P, et al. 1999. Expression of heparan sulphate D glucosaminyl 3-O sulphotransferase isoforms reveals novel substrate specificities. J Biol Chem, 274(8): 5185-5192.
48. Lycke E, Johansson M, Svennerholm B, et al. 1991. Binding of herpes simplex virus to cellular heparan sulphate, an initial step in the adsorption process. J Gen Virol, 72(Pt 5): 1131-1137.
49. Marchetti M, Longhi C, Conte M P, et al. 1996. Lactoferrin inhibits herpes simplex virus type1 adsorption to Vero cells. Antiviral Res, 29(2-3): 221-231.
50. Marchetti M, Pisani S, Antonini G, et al. 1998. Metal complexes of bovine lactoferrin inhibit in vitro replication of herpes simplex virus type 1 and 2. Biometals, 11(2): 89-94.
51. Mardberg K, Trybala E, Glorioso J C, et al. 2001. Mutational analysis of the major heparan sulfate-binding domain of herpes simplex virus type 1 glycoprotein C. J Gen Virol, 82(Pt 8): 1941-1950.
52. McKeehan W L, Wu X, Kan M. 1999. Requirement for anticoagulant heparan sulfate in the fibroblast growth factor receptor complex. J Biol Chem, 274(31): 21511-21514.
53. Montgomery R I, Warner M S, Lum B J, et al. 1996. Herpes simplex virus-1 entry into cells mediated by a novel member of the TNF/NGF receptor family. Cell, 87(3): 427-436.
54. Nahmias A J, Kibrick S. 1964. Inhibitory effect of heparin on herpes simplex virus. J Bacteriol, 87(5): 1060-1066.
55. Neyts J, Snoeck R, Schols D, et al. 1992. Sulfated polymers inhibit the interaction of human cytomegalovirus with cell surface heparan sulfate. Virology, 189(1): 48-58.
56. Nicola A V, McEvoy A M, Straus S E. 2003. Roles for endocytosis and low pH in herpes simplex virus entry into HeLa and Chinese hamster ovary cells. J Virol, 77(9): 5324-5332.
57. Nyberg K, Ekblad M, Bergstrom T, et al. 2004. The low molecular weight heparan sulfate-mimetic, PI-88, inhibits cell-to-cell spread of herpes simplex virus. Antiviral Res, 63(1): 15-24.
58. O'Donnell C D, Tiwari V, Oh M J, et al. 2006. A role for heparan sulfate 3-O sulfotransferase isoform 2 in herpes simplex virus type 1 entry and spread. Virology, 346(2): 452-459.
59. Pertel P E, Fridberg A, Parish M L, et al. 2001. Cell fusion induced by herpes simplex virus glycoproteins gB, gD, and gH-gL requires a gD receptor but not necessarily heparan sulfate. Virology, 279(1): 313-324.
60. Ponce N M, Pujol C A, Damonte E B, et al. 2003. Fucoidans from the brown seaweed Adenocystis utricularis: Extraction methods, antiviral activity and structural studies. Carbohydr Res, 338(2): 153-165.
61. Preeprame S, Hayashi K, Lee J, et al. 2001. A novel antivirally active fucan sulfate derived from an edible brown alga, Sargassum horneri. Chem Pharm Bull (Tokyo), 49(4): 484-485.
62. Raghuraman A, Tiwari V, Zhao Q, et al. 2007. Viral inhibition studies on sulfated lignin, a chemically modified biopolymer and a potential mimic of heparan sulfate. Biomacromolecules, 8(5): 1759-1763.
63. Rosenberg R D, Shworak N W, Liu J, et al. 1997. Heparan sulfate proteoglycans of the cardiovascular system. Specific structures emerge but how is synthesis regulated? J Clin Invest, 99(9): 2062-2070.
64. Scanlan P M, Tiwari V, Bommireddy S, et al. 2005. Spinoculation of heparan sulfate deficient cells enhances HSV-1 entry, but does not abolish the need for essential glycoproteins in viral fusion. J Virol Methods, 128(1-2): 104-112.
65. Shieh M T, WuDunn D, Montgomery R I, et al. 1992. Cell surface receptors for herpes simplex virus are heparan sulphate proteoglycans. J Cell Biol, 116(5): 1273-1281.
66. Shukla D, Liu J, Blaiklock P, et al. 1999. A novel role for 3-O-sulfated heparan sulfate in herpes simplex virus 1 entry. Cell, 99(1): 13-22.
67. Shukla D, Spear P G. 2001. Herpesviruses and heparan sulfate: An intimate relationship in aid of viral entry. J Clin Invest, 108(4): 503-510.
68. Shworak N W, Liu J, Petros L M, et al. 1999. Multiple isoforms of heparan sulfate D glucosaminyl 3-O-sulfotrans-ferase. Isolation, characterization, and expression of human cDNAs and identification of distinct genomic loci. J Biol Chem, 274(8): 5170-5184.
69. Shworak N W, HajMohammadi S, de Agostini A I, et al. 2002. Mice deficient in heparan sulfate 3-O-sulfotrans-ferase-1: Normal hemostasis with unexpected perinatal phenotypes. Glycoconj J, 19(4-5): 355-361.
70. Skrincosky D, Hocknell P, Whetter L, et al. 2000. Identification and analysis of a novel heparin-binding glycoprotein encoded by human herpesvirus 7. J Virol, 74(10): 4530-4540.
71. Spear P G, Longnecker R. 2003. Herpesvirus entry: An update. J Virol, 77(19): 10179-10185.
72. Spear P G, Shieh M T, Herold B C, et al. 1992. Heparan sulfate glycosaminoglycans as primary cell surface receptors for herpes simplex virus. Adv Exp Med Biol, 313: 341-353.
73. Svennerholm B, Jeansson S, Vahlne A, et al. 1991. Involvement of glycoprotein C (gC) in adsorption of herpes simplex virus type 1 (HSV-1) to the cell. Arch Virol, 120(3-4): 273-279.
74. Tal-Singer R, Peng C, Ponce De Leon M, et al. 1995. Interaction of herpes simplex virus glycoprotein gC with mammalian cell surface molecules. J Virol, 69(7): 4471-4483.
75. Tiwari V, Clement C, Duncan M B, et al. 2004. A role for 3-O-sulphated heparan sulphate in cell fusion induced by herpes simplex virus type 1. J Gen Virol, 85(Pt 4): 805-809.
76. Tiwari V, O'Donnell C D, Oh M J, et al. 2005. A role for 3-O-sulfotransferase isoform-4 in assisting HSV-1 entry and spread. Biochem Biophys Res Commun, 338(2): 930-937.
77. Tiwari V, O'Donnell, C, Copeland R J, et al. 2007. Soluble 3-O-sulfated heparan sulfate can trigger herpes simplex virus type 1 entry into resistant Chinese hamster ovary (CHO-K1) cells. J Gen Virol, 88:1075-1079.
78. Tiwari V, ten Dam G B, Yue B Y, et al. 2007. Role of 3-O-sulfated heparan sulfate in virus-induced polykary-ocyte formation. FEBS Lett, 581(23): 4468-4472.
79. Trybala E, Bergstrom T, Svennerholm B, et al. 1994. Localization of a functional site on herpes simplex virus type 1 glycoprotein C involved in binding to cell surface heparan sulphate. J Gen Virol, 75(Pt 4): 743-752.
80. Trybala E, Bergstrom T, Spillmann D, et al. 1998. Interaction between pseudorabies virus and heparin/heparan sulfate. Pseudorabies virus mutants differ in their interaction with heparin/heparan sulfate when altered for specific glycoprotein C heparin-binding domain. J Biol Chem, 273(9): 5047-5052.
81. Trybala E, Liljeqvist J A, Svennerholm B, et al. 2000. Herpes simplex virus types 1 and 2 differ in their interaction with heparan sulfate. J Virol, 74(19): 9106-9114.
82. Trybala E, Olofsson S, Mardberg K, et al. 2004. Structural and functional features of the polycationic peptide required for inhibition of herpes simplex virus invasion of cells. Antiviral Res, 62(3): 125-134.
83. Tyagi M, Rusnati M, Presta M, et al. 2001. Internali-zation of HIV-1 Tat requires cell surface heparan sulfate proteoglycans. J Biol Chem, 276(5): 3254-3261.
84. Vanderplasschen A, Bublot, M, Dubuisson J, et al. 1993. Attachment of the gammaherpesvirus bovine herpesvirus 4 is mediated by the interaction of gp8 glycoprotein with heparinlike moieties on the cell surface. Virology, 196(1): 232-240.
85. Wang F Z, Akula S M, Pramod N P, et al. 2001. Human herpesvirus 8 envelope glycoprotein K8.1 A interaction with the target cells involves heparan sulfate. J Virol, 75(16): 7517-7527.
86. WuDunn D, Spear P G. 1989. Initial interaction of herpes simplex virus with cells is binding to heparan sulphate. J Virol, 63(1): 52-58.
87. Xia G, Chen J, Tiwari V, et al. 2002. Heparan sulfate 3-O-sulfotransferase isoform 5 generates both an anti-thrombin-binding site and an entry receptor for herpes simplex virus, type 1. J Biol Chem, 277(40): 37912-37919.
88. Xu D, Moon A, Song D, et al. 2008. Engineering sulfotransferases to modify heparan sulfate. Nat Chem Biol, 4(3): 200-202.
89. Xu D, Tiwari V, Xia G, et al. 2005. Characterization of heparan sulphate 3-O sulphotransferase isoform 6 and its role in assisting the entry of herpes simplex virus type 1. Biochem J, 385(Pt 2): 451-459.
90. Yabe T, Shukla D, Spear P G, et al. 2001. Portable sulphotransferase domain determines sequence specificity of heparan sulphate 3-O-sulphotransferases. Biochem J, 359(Pt 1): 235-241.
91. Yamaguchi Y. 2001. Heparan sulfate proteoglycans in the nervous system: their diverse roles in neurogenesis, axon guidance, and synaptogenesis. Semin Cell Dev Biol, 12: 99-106.
92. Yoon M, Zago A, Shukla D, et al. 2003. Mutations in the N-termini of herpes simplex virus type 1 and 2 gDs alter functional interactions with the entry/fusion receptors HVEM, Nectin-2, and 3-O-sulphated heparan sulphate but not with Nectin-1. J Virol, 77(17): 9221-9231.